SecBot SecBot
8-K ·Filed Apr 28, 2026

VNRX

VOLITIONRX LTD
NEUTRAL
Impact 3/10
Horizonimmediate Processed6mo ago SEC0001477932-26-002619
8-K context-dependent: Items 3.03
Actionable Insight • Neutral

The reverse split is a routine administrative action with no fundamental business change. Monitor for potential NYSE American continued listing compliance benefits, but no immediate trading catalyst.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
VNRX ▼ -62.12% at T+60d
NEUTRAL call -62.12% · α vs SPY -66.23% · entry $2.64 → $1.00
Entry = T+0 close
Apr 28, 2026
via day close
T+1d
-0.76%
call -0.76% · α -1.78%
$2.62
settled 6mo ago
T+5d
-5.68%
call -5.68% · α -8.79%
$2.49
settled 6mo ago
T+20d
+9.09%
call +9.09% · α +3.04%
$2.88
settled 5mo ago
T+60d
-62.12%
call -62.12% · α -66.23%
$1.00
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

VolitionRx filed a Certificate of Amendment to effect a 1-for-20 reverse stock split, effective April 28, 2026. This is a routine capital structure adjustment with no financial data or operational changes reported.

Key Facts

  • Reverse stock split at a 1-for-20 ratio, effective 12:01 a.m. ET on April 28, 2026
  • Authorized shares reduced from 325,000,000 to 325,000,000 (no change in authorized count)
  • Fractional shares rounded up to one whole share
  • Stockholder approval obtained at special meeting on March 31, 2026
  • No financial statements, revenue, earnings, or guidance provided in this filing

Financial Impact

No financial impact disclosed; reverse split is a mechanical share consolidation with no change to market cap or fundamentals

shares outstanding

Risk Factors

  • Reverse splits can signal low stock price and potential delisting risk, though not explicitly stated here
  • No operational or financial updates provided in this filing

Market Snapshot

Exchange
NYSE
Sector
In Vitro & In Vivo Diagnostic Substances
Analyst Consensus
82% bullish (11 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001477932-26-002619
Document: vnrx_ex31.htm0001477932-26-002619
Document: 0001477932-26-002619-index-headers.html0001477932-26-002619
Document: 0001477932-26-002619-index.html0001477932-26-002619
Document: 0001477932-26-002619.txt0001477932-26-002619
19 reports for VNRX
Performance horizon
100% Hit rate @ T+60 3 of 3 directional calls Went positive at some point 12 of 13 best @ T+60▲ +83.65%Jul 20, 2026
Filters
Rows
Reports for VNRX — sortable, filterable
TypeNow
Sep 25, 2026
4w ago
8-K
BEARISH ★ 7/10
$0.2529awaiting T+60—$0.1800 (+28.83%)
Sep 16, 2026
5w ago
SC 13D/A
NEUTRAL ★ 3/10
$0.2849awaiting T+60—$0.1800 (−36.82%)
Sep 15, 2026
5w ago
8-K
BEARISH ★ 5/10
$0.2749awaiting T+60—$0.1800 (+34.52%)
Sep 11, 2026
6w ago
EFFECT
BEARISH ★ 7/10
$0.3102awaiting T+60—$0.1800 (+41.97%)
Sep 8, 2026
6w ago
S-3/A
BEARISH ★ 7/10
$0.3400awaiting T+60—$0.1800 (+47.06%)
Sep 1, 2026
7w ago
8-K
BEARISH ★ 6/10
$0.3800awaiting T+60—$0.1800 (+52.63%)
Aug 24, 2026
9w ago
8-K
BEARISH ★ 6/10
$0.3846awaiting T+60—$0.1800 (+53.20%)
Aug 7, 2026
11w ago
8-K
BEARISH ★ 6/10
$0.7700awaiting T+60—$0.1800 (+76.62%)
Jul 20, 2026
14w ago
EFFECT
BEARISH ★ 6/10
$1.13 $0.1847▲ +83.65%▲ +88.50%$0.1800 (+84.07%)
Jun 18, 2026
18w ago
8-K
BEARISH ★ 6/10
$1.34awaiting T+60—$0.1800 (+86.57%)
Showing 10 of 19

US Market Status

Market Closed — Opens in 4h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 28, 2026